Remdesivir approved by the Therapeutic Goods Administration for severe coronavirus cases - ABC News

"Remdesivir is the most promising treatment option so far to reduce hospitalisation time for those suffering from severe coronavirus infections," the TGA said in a statement.

"None of the international trials that have been conducted into Remdesivir have shown marked results but they have shown some results that indicate that it might be effective in patients with moderate to severe coronavirus disease," Dr Coatsworth said on Saturday.

"The current stockpile in Australia will be enough for the coming weeks," Dr Coatsworth said, adding that there were only 16 people in intensive care nationwide as of Saturday afternoon.

"It will be an important part of treatment in the absence of a vaccine," Mr Chalmers said on Saturday.

Dr Coatsworth said Remdesivir had been used selectively in Australia earlier in the pandemic as well as recently during Victoria's latest outbreak.